Format

Send to

Choose Destination
J Diabetes Sci Technol. 2012 Jul 1;6(4):797-801.

Undeniable need for ultrafast-acting insulin: the pediatric perspective.

Author information

1
Division of Pediatric Endocrinology and Diabetes, Yale University School of Medicine, New Haven, Connecticut 06520, USA. Eda.Cengiz@yale.edu

Abstract

Insulin therapy in youth with type 1 diabetes mellitus (T1DM) poses a special challenge because childhood is an unsteady state with increasing weight, height, and caloric needs, leading to varying insulin requirements. The current rapid-acting insulin analogs are not as fast and short-acting as needed to meet these challenges. This review describes the unique characteristics of insulin action in youth with T1DM based on previously published euglycemic clamp studies. It also explains the rationale behind the need for ultrafast-acting insulins to advance open- and closed-loop insulin therapy for the pediatric population with diabetes. Lastly, it briefly summarizes ongoing and future projects to accelerate insulin action in youth with T1DM.

PMID:
22920804
PMCID:
PMC3440149
DOI:
10.1177/193229681200600409
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center